Board of Directors

Sérgio Simões

PharmD, MSc, Ph D
Co-Founder and Chairman

 

Short biography

Sérgio Simões has a degree in Pharmaceutical Sciences, a Master degree in Engineering Sciences and a Ph.D. in Pharmaceutics. He has a position as assistant professor at Faculty of Pharmacy of the University of Coimbra – Portugal, he is Member of the Board and Vice-president for business and product development of Bluepharma (a Pharmaceutical Company located in Portugal) and a research member at the Center for Neurosciences and Cell Biology, University of Coimbra. His research activity has been focused on the development of targeted nanocarriers for drug and nucleic acid delivery aiming at their application for gene therapy. He has published more than 150 SCI journal papers, 11 book chapters, 9 patents and he is the author/co-author of over 250 presentations in international conferences and workshops. Over the last years, he has conducted several research projects in the field of Biotechnology and gained a significant expertise on the development, industrial transfer and manufacturing of pharmaceutical dosage forms for the European and US market. Co-founder and share-holder of companies operating in the field of Pharmaceutics/drug development.

 

Vera_website

Vera Moura

PharmD, Ph D
Co-Founder and Chief Executive Officer

 

Short biography

Vera Moura completed her BSc degree in Pharmaceutical Sciences and her PhD in Pharmaceutical Technology from the University of Coimbra, Portugal, in the area of targeted therapies in Oncology. She is co-author of three patents granted in USA, 2 PCTs currently under evaluation and of scientific publications in peer-reviewed journals. She was awarded with the best thesis award 2011 (2nd place) from the Portuguese Society of Pharmaceutical Sciences (SPCF) and the Spanish-Portuguese Local Chapter of Controlled Release Society (SPLC-CRS). As co-author of the project Smart Medicines, she was awarded in the Entrepreneurship contests “Arrisca Coimbra 2009” and “Idea to Product 2010 (I2P)”. She has collaborated with the Tech Transfer Office from the University of Coimbra as a Manager for Science and Technology and was Mentor in the Iberian Entrepreneurship Course CEBT 2011, with the University of Coimbra, University of Beira Interior and University of Aveiro, CEC/CCIC (Conselho Empresarial do Centro / Câmara de Comércio e Indústria do Centro), and Castilla y Leon: Universidad de Salamanca, Universidad Pontificia de Salamanca, Fundación Universidad de Valladolid e Universidad de León. Her research work has led to the creation of TREAT U, from which she is co-founder and current CEO. 

 

Miguel Botto

Member of the Board

 

Short biography

Miguel Botto is a member of the Board at Portugal Ventures. Experience gathered mainly in areas related to venture capital, since 1992, specifically in several companies such as Enoforum, Altitude, Micropolis, Cotflax and TP – Térmica Portuguesa. Degree in Management, obtained at Instituto Superior de Economia de Lisboa and at HEC School (University of Lausanne). Post-graduate degree in Finance and Strategic Management, granted by Universidade Católica, and in Leadership, obtained at Harvard University.

 

Paulo Barradas

PharmD
Member of the Board

 

Short biography

Paulo Barradas is Chief Executive Officer, Member of the Board and Shareholder of Bluepharma, S.A. with more that 20 years of professional experience in creating, managing and overseeing companies.

 

Tony Cruz

Ph D
Member of the Board

 

Short biography

Tony Cruz is one of the founders of Transition Therapeutics and has held the position of Chief Executive Officer of Transition Therapeutics since its inception in July 1998. He was Co-Founder, Vice-President and Director at Angiotech Pharmaceuticals Inc. Has been a Senior Scientist at Mount Sinai Hospital since 1995 and was the CEO and President of the Canadian Arthritis Network until 2001. He has also served as a consultant for biotechnology companies and investment firms.